News

06-09-2018

Hammarskiöld & Co advised Medical Prognosis Institute A/S in connection with the cross-border merger between Medical Prognosis Institute and Oncology Venture Sweden AB (publ)

Read more

05-09-2018

Hammarskiöld & Co advised Skandinaviska Enskilda Banken (Sole Global Coordinator and Bookrunner) in connection with the IPO of Projektengagemang Sweden AB (publ) on Nasdaq Stockholm

Read more

21-08-2018

Competition law must be taken seriously in Mergers and Acquisitions (article in Swedish)

Read more

20-08-2018

Malin Albert has joined Hammarskiöld & Co and strengthens the company’s commitment to Life Science and Competition law (article in Swedish)

Read more

11-04-2018

Hammarskiöld & Co are proud to announce the collaboration with charity foundation Musikbojen

Read more

29-01-2018

Hammarskiöld & Co advises Scania in 10 MEUR strategic partnership investment in Northvolt

Read more

02-01-2018

Hammarskiöld & Co represents Scania in appeal against record antitrust fine

Read more

14-12-2017

Hammarskiöld & Co are representing Länsförsäkringar Mäklarservice (the insurance broker of the Länsförsäkringar insurance group) in the ongoing investigation by the Swedish Competition Authority (“SCA”) concerning suspected/alleged violations of competition law rules in connection with tendering for insurance contracts.

Read more

Hammarskiöld & Co advised Atvexa AB (publ) and DNB Markets in connection with the IPO of Atvexa

Read more

08-12-2017

Hammarskiöld & Co advised Carnegie Investment Bank, ABG Sundal Collier, DNB Markets and Kempen Co N.V. (Joint Bookrunners) in connection with the directed share issue in Wilson Therapeutics AB (publ)

Read more